
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES99
The Cochrane review, ACEI and A2RB antagonists for preventing the progression of diabetic kidney disease, identified ACE compared with placebo reduced the progression from micro- to macroalbuminuria, increased the regression from micro- to normoalbuminuria, and reduced the risk of ESRD.237

[@2005]

